BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  HOOKIPA Takes Charge of Gilead-partnered HIV Program

  HOOKIPA Pharma Inc.’s shares have soared after stating it amended and restated a collaboration and license agreement with Gilead Sciences to develop immunotherapies against HIV.

  February 16, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Legend’s Lymphoma Drug on Hold After Patient Reaction

  The FDA sent an email holding the planned Phase I trial for LB1901 after the first and only patient dosed was found to have low CD4+ T-cell counts in the peripheral blood.

  February 16, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Global Roundup: Genuv Adds AI to Aid Discovery of Alzheimer’s, ALS Therapies

  Biopharma and life sciences companies from across the globe provide updates to their pipelines and businesses.

  February 16, 2022

   · 

  8 min read

   · 

  Alex Keown
• 

  Drug Development

  Mirati KRAS Inhibitor Snags December Decision Date

  The NDA acceptance is based on positive results from the KRYSTAL-1 trial, which looked into the effect of using 600mg BID of adagrasib in patients.

  February 16, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Sage and Biogen, BMS Boast Positive Data in Depression, HCM

  Sage and Biogen announced positive topline results from the Phase III study of zuranolone that showed a rapid reduction in depressive symptoms after three days.

  February 16, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  BioNTainers Bring BioNTech “One Step Closer” to Providing Global mRNA Vaccines Access

  BioNTech is opening one of the largest mRNA vaccines manufacturing facilities in the world to expand the availability of the COVID-19 vaccine.

  February 16, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Infusion Clinics are Key to Preparing Psychedelics for the Healthcare System

  Psychedelics therapies – serotonin 2 A receptor agonists – are trying to enter mainstream medicine for depression and as anti-inflammatory or neuroprotective treatments.

  February 16, 2022

   · 

  6 min read

   · 

  Gail Dutton
• 

  Business

  Moderna Expands Asian Presence with Four New Subsidiaries

  Moderna announced plans to expand in Asia with the opening of four new subsidiaries in Malaysia, Taiwan, Singapore and Hong Kong.

  February 16, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  COVID-19 Update: Does Omicron Fading Mark the Pandemic’s Final Stages?

  With the Omicron surge waning, at least in the U.S., there is speculation that the COVID-19 pandemic may be in its end stages. Some experts, however, warn that this could be premature.

  February 16, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Business

  Third Harmonic Bio Launches with $155M to Tackle Mast Cell-Driven Diseases

  On Wednesday, Third Harmonic Bio closed on Series B financing, bringing the total capital raised to $155 million.

  February 16, 2022

   · 

  3 min read

   · 

  Claudia Beezhold